0
Nov 19 (Reuters) – Medivir AB: * MEDIVIR: FDA GRANTS MEDIVIR’S MIV-711 RARE PEDIATRIC DISEASE DESIGNATION FOR OSTEOGENESIS IMPERFECTA * MIV-711 MAY QUALIFY FOR PRIORITY REVIEW VOUCHER – TRANSFERABLE
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)